跳至主要内容
临床试验/EUCTR2008-002958-37-IT
EUCTR2008-002958-37-IT进行中(未招募)不适用

Differences in dynamic contrast-enhanced (DCE) MRI measurements using Magnevist (Gd-DTPA) and Vas-ovist in patients with untreated squamous cell cervical carcinoma. - ND

ISTITUTO EUROPEO DI ONCOLOGIA0 个研究点开始时间: 2008年7月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Adult patients (18 years and older)
  • Patients willing and able to undergo all study procedures
  • Patients affected by untreated histologically diagnosed SCCC.
  • Patients who have signed the written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • History of severe allergic reaction or allergic reaction to MR contrast media.
  • Pregnant or lactating women.
  • Not being able to remain lying down for at least 45-60 min (e.g., patients with dyspnea at rest, severe pain at rest, severe back pain).
  • Patients with a contraindication to MRI such as pacemaker, aneurysm clip, or severe claustrophobia.
  • Uncooperative patients, in the investigator?s opinion.
  • Patients affected by severe renal impairment (GFR<30mL/min/1.73m2).
  • Patients participating in another clinical trial.

研究者

相似试验